• Access Breakthrough Autologous Biologic Capabilities with EXO Advantage

  • Consistently Over 10 Billion Platelets Delivered, Target Dose for Knee OA

  • Common Easy to Use Platform to Process PRP, Autologous Exosomes, BMA, Ex-vivo Photobiomodulation and Adipose

  • Affordable Solutions for Patients and Clinics

A badge with the text "FDA Cleared (510k)" on it.

FDA 510(K), MDSAP

EXO Advantage delivers the equipment and protocols available to the nation’s blood banks but customized to meet the needs of the clinic.

Orange arrow.

Research has shown that an absolute count of over 10 billion platelets and over 1.5 billion platelets per ml is the threshold for PRP dosage to optimally treat knee OA. The Exo Advantage system consistently delivers over 10 billion platelets.

Orange arrow.
Orange arrow.

Are you pre-conditioning your samples using photobiomodulation?

Does your clinical regimen include supplementing your PRP with concentrated proteins and exosomes from plasma?

Orange arrow.
Orange arrow.

Are you processing PRP, Exosomes, bone marrow, and adipose using a common platform to improve workflow?

Access superior biologics at a guaranteed lower cost and a threshold over 10 billion platelets for your typical OA patient.

At Exo Advantage, we believe clinicians deserve access to safe, novel, and affordable cutting-edge solutions for treating patients.

Providing the regenerative medicine community with cutting-edge protocols and devices to consistently meet or exceed dose thresholds at the lowest cost.

  • Unique Capabilities

  • Industry-Leading Protocols Set By The Red Cross & Blood Banks

  • Improved Quality of Biologics - Higher Platelet Count per Sample

  • Increased Efficiency and Ease of Use with Common Platform

  • Lower Costs and Transparent Pricing

You Deserve a MUCH Better Product at a MUCH Better Price

An orange of a provider with a stethoscope around their neck.

BETTER FOR PROVIDERS

Adopt cutting-edge protocols for higher dose, mitochondrial repair, and more concentrated exosome, protein and growth factors

An orange icon of a patient hooked up to an IV.

BETTER FOR PATIENTS

Superior Biologics Lead to Better Patient Outcomes

We can dramatically lower your costs and improve the quality of the biologics you use!

Dr. Paul Tortland in a medical examination room.

Dr. Paul Tortland, DO, FAOASM

“I have worked with this management team for over 20 years beginning with Harvest Technologies. The products they have brought to our clinic have improved patient care and made our clinics more profitable.”